Zhi Yao Selected Research

ASN 1377642

7/2013

Roles of full-length and truncated neurokinin-1 receptors on tumor progression and distant metastasis in human breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhi Yao Research Topics

Disease

79	Neoplasms (Cancer) 01/2022 - 11/2003
34	Neoplasm Metastasis (Metastasis) 05/2022 - 06/2003
22	Breast Neoplasms (Breast Cancer) 01/2022 - 04/2007
16	Inflammation (Inflammations) 03/2022 - 09/2006
16	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 04/2004
16	Prostatic Neoplasms (Prostate Cancer) 10/2017 - 06/2003
10	Lung Neoplasms (Lung Cancer) 11/2018 - 09/2005
9	Infections 10/2021 - 03/2005
8	Carcinogenesis 01/2022 - 05/2011
8	Hypothyroidism 05/2021 - 01/2015
8	Carcinoma (Carcinomatosis) 11/2012 - 01/2006
7	Insulin Resistance 12/2020 - 12/2007
7	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2019 - 03/2013
6	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 07/2009
6	Fibrosis (Cirrhosis) 01/2020 - 10/2008
6	Melanoma (Melanoma, Malignant) 01/2020 - 01/2006
6	Liver Cirrhosis (Hepatic Cirrhosis) 01/2019 - 01/2016
6	Multiple Sclerosis 01/2019 - 03/2013
5	Hypoxia (Hypoxemia) 01/2020 - 12/2011
5	Leukemia 06/2017 - 04/2007
5	Demyelinating Diseases (Demyelinating Disease) 01/2017 - 03/2013
4	Body Weight (Weight, Body) 12/2020 - 02/2004
4	Parkinson Disease (Parkinson's Disease) 12/2018 - 03/2009
4	Liver Neoplasms (Liver Cancer) 01/2018 - 11/2008
4	Mitochondrial Diseases (Mitochondrial Disease) 01/2017 - 09/2009
4	Ovarian Epithelial Carcinoma 06/2009 - 10/2005
3	Experimental Melanoma 01/2021 - 04/2007
3	Thyroiditis 09/2020 - 01/2017
3	Obesity 01/2020 - 12/2011
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 01/2012
3	Pancreatic Neoplasms (Pancreatic Cancer) 11/2017 - 07/2014
2	Peripheral Nerve Injuries 01/2022 - 10/2017
2	Wounds and Injuries (Trauma) 01/2021 - 01/2017
2	Atherosclerosis 01/2021 - 06/2012
2	Glucose Intolerance 12/2020 - 04/2017
2	Necrosis 01/2020 - 10/2005
2	Pathologic Processes 01/2019 - 01/2019
2	Adenocarcinoma of Lung 11/2018 - 09/2013

Drug/Important Bio-Agent (IBA)

34	Proteins (Proteins, Gene)FDA Link 01/2020 - 06/2003
14	Pharmaceutical PreparationsIBA 01/2022 - 04/2007
11	Messenger RNA (mRNA)IBA 11/2018 - 06/2004
10	CytokinesIBA 01/2020 - 02/2004
10	tripeptide tyroservatideIBA 01/2016 - 01/2006
9	CateninsIBA 01/2020 - 02/2012
9	H-Tyr-Ser-Leu-OHIBA 01/2018 - 10/2005
9	Therapeutic UsesIBA 01/2018 - 01/2006
8	Biological ProductsIBA 01/2022 - 02/2004
8	Glucose (Dextrose)FDA LinkGeneric 12/2020 - 12/2007
8	Interleukin-6 (Interleukin 6)IBA 01/2020 - 02/2004
8	Peptides (Polypeptides)IBA 01/2016 - 07/2008
7	MicroRNAs (MicroRNA)IBA 01/2021 - 02/2010
6	Interleukin-17 (Interleukin 17)IBA 05/2020 - 11/2009
6	Conditioned Culture MediaIBA 01/2018 - 09/2005
6	LigandsIBA 01/2017 - 11/2003
5	Thyroxine (Levothyroxine)FDA LinkGeneric 05/2021 - 06/2016
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2015
5	Small Interfering RNA (siRNA)IBA 12/2020 - 03/2012
5	Long Noncoding RNAIBA 01/2020 - 07/2016
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 02/2004
5	Transcription Factors (Transcription Factor)IBA 01/2019 - 05/2010
5	ChemokinesIBA 07/2016 - 06/2007
5	Interleukin-8 (Interleukin 8)IBA 09/2015 - 10/2005
5	Phosphatidylethanolamine Binding ProteinIBA 07/2009 - 06/2003
4	HomocysteineIBA 05/2021 - 01/2015
4	Estrogens (Estrogen)FDA Link 12/2015 - 10/2005
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2015 - 11/2003
4	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 07/2014 - 09/2006
4	Proliferating Cell Nuclear Antigen (PCNA)IBA 08/2009 - 09/2005
3	Adenosine (Adenocard)FDA LinkGeneric 03/2022 - 01/2022
3	Phosphotransferases (Kinase)IBA 01/2021 - 02/2014
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 12/2020 - 01/2015
3	AntibodiesIBA 09/2020 - 06/2017
3	cytotoxic necrotizing factor type 1IBA 01/2020 - 10/2017
3	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2020 - 11/2014
3	Protein Isoforms (Isoforms)IBA 11/2018 - 07/2013
3	AdiponectinIBA 01/2017 - 07/2014
3	Cadherins (E-Cadherin)IBA 01/2017 - 03/2011
3	Interleukin-4 (Interleukin 4)IBA 12/2015 - 02/2011
3	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 08/2014 - 06/2003
3	CalciumIBA 01/2012 - 10/2005
3	Histones (Histone)IBA 01/2011 - 03/2006
3	RANK LigandIBA 04/2007 - 11/2003
3	Prostate-Specific Antigen (Semenogelase)IBA 03/2006 - 11/2003
2	Carrier Proteins (Binding Protein)IBA 05/2022 - 04/2015
2	PlatinumIBA 01/2022 - 06/2017
2	Indicators and Reagents (Reagents)IBA 01/2022 - 06/2011
2	ChromatinIBA 01/2022 - 02/2012
2	Beclin-1IBA 10/2021 - 01/2019
2	Tamoxifen FDA LinkGeneric 01/2021 - 05/2010
2	fibroblast growth factor 21IBA 12/2020 - 06/2016
2	Oncogene Proteins (Oncogene Protein)IBA 01/2020 - 01/2019
2	InflammasomesIBA 12/2019 - 01/2019
2	Micrococcal NucleaseIBA 01/2019 - 01/2019

Therapy/Procedure

18	Therapeutics 01/2022 - 01/2006
8	Drug Therapy (Chemotherapy) 01/2022 - 09/2008
5	Immunotherapy 01/2021 - 11/2011
4	Liver Transplantation 02/2016 - 08/2006
3	Radiotherapy 01/2020 - 07/2015
3	Intraperitoneal Injections 11/2008 - 02/2004
2	Transplantation 01/2022 - 03/2005